NASDAQ: FACTFact II Acquisition Corp Stock
$10.71+0.00 (+0%)
Updated Sep 17, 2026
FACT Price
$10.71
Fair Value Price
N/A
Market Cap
$260.48M
52 Week Low
$7.23
52 Week High
$12.68
P/E
66.94x
P/B
-26.75x
P/S
N/A
PEG
2.75x
Dividend Yield
N/A
Revenue
$0.00
Earnings
$3.83M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.03
Operating Cash Flow
-$918k
Beta
0.01
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
FACT Overview
Freedom Acquisition I Corp. currently conducts no material business activities. Its sole purpose is to identify and execute a business combination, potentially through a merger, asset acquisition, share purchase, stock exchange, or corporate reorganization, involving one or more other enterprises. The company was established in 2020 and is headquartered in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine FACT's potential to beat the market
- FACT doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Defense
Industry Rating
D
FACT
RankedUnranked of 84
RankedUnranked of 84
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $65.71 | A | |
| $13.64 | A | |
| $40.96 | A |
Be the first to know about important FACT news, forecast changes, insider trades & much more!
FACT News
Overview
Due Diligence Score
–
Industry Average (34)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how FACT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
FACT ($10.71) is trading above its intrinsic value of $1.95, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
FACT is poor value based on its earnings relative to its share price (66.94x), compared to the US market average (44.48x)
P/E vs Market Valuation
FACT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more FACT due diligence checks available for Premium users.
Valuation
FACT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
66.94x
Industry
14.28x
Market
44.48x
FACT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
FACT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
FACT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-26.75x
Industry
9.97x
FACT price to earnings growth (PEG)
For valuing profitable companies with growth potential
FACT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
FACT's financial health
Profit margin
Revenue
$0.0
Net Income
$859.9k
Profit Margin
0%
FACT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$187.1M
Liabilities
$10.0M
Debt to equity
-1.03
FACT's short-term assets ($255.80k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
FACT's long-term liabilities ($9.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
FACT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
FACT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$242.4k
Investing
$0.0
Financing
$0.0
FACT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
FACT vs Defense Stocks
Fact II Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.